Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Add To Watchlist

TSX:LABS - Post Discussion

Medipharm Labs Corp > FDA

View:

Post by Solid1 on Nov 28, 2022 11:14am

FDA

just enter Medipharm Labs
https://www.accessdata.fda.gov/scripts/cder/drls/default.cfm
So beautiful

224

Comment

Comment by QuantumFlesh on Nov 28, 2022 11:52am

This post has been removed in accordance with Community Policy

Comment by mdjbrown on Nov 28, 2022 12:30pm

Everything certainly appears to be falling into place for Medipharm Labs. Prsident Bidens announcement will be the incing on the cake and I assume the cherry will be added shortly afterwards https://www.newswire.ca/news-releases/medipharm-labs-enters-united-states-pharmaceutical-market-with-submission-of-fda-dmf-830091598.html

Comment

Comment by Starkicker on Nov 28, 2022 1:40pm

Just playing the devil's advocate (again) but to access the NASDAQ this is going to require at least a 40:1 reverse split (likely higher). It would be great to grow the SP organically to get there but the timing will be way off and revenue won't grow that fast. Probably why tthe outlook looks so good but SP isn't climbing. If you want to know what a reverse split does to a stock just ...more

Comment

Comment by Solid1 on Nov 28, 2022 1:57pm

Oh, stop with the rhetoric. This share has been sold short to the hilt... When the news comes out that we're seeing here, this stock is going to be on the NASDAQ very quickly... No other cannabis company has what Medipharm Labs has.

Comment

Comment by mdjbrown on Nov 28, 2022 2:00pm

Sk, that is a big assumtion that the shareprice does not go > $1.00 after a series of carefully calculated strategic announcements. Not sure where you get 40 - 1 as NASDAQ minimum requirements are $1.00 per share are they not? Revenue will increase quarterly as with any prudently run company. Any announcement made by the corporation linking Medipharm as the supplier for a generic ...more

Comment

Comment by Solid1 on Nov 28, 2022 2:02pm

FDA registration DMF Global pharmaceutical partner DEL CD licence TOP Management No debts Cash And a lot of markets Europe/USA/Latin America

Comment

Comment by Starkicker on Nov 28, 2022 2:26pm

You forgot the $4 US minimum share price to list on NASDAQ.

Comment

Comment by mdjbrown on Nov 28, 2022 2:52pm

Sk, just curious but where did the notion of a NASDAQ listing come from as I can not find any info that Medipharm is pursuing that option? Medipharm is already in the US on the OTC under MEDIF, and uplisting to the big boards has been done by several other mj players in the past, so I dont see that being an issue in the future, and if things do go according to what many see happening here ...more

Comment

Comment by Starkicker on Nov 28, 2022 3:58pm

Hey MDJ, The OTC (pink sheets) exchange is for companies that don't meet the requirements of the major exchanges. Generally speaking, institutional invstors won't go anywhere near them. I figured with all of the chatter about the anticipation of Biden legalizing cannabis federally and FDA approvals, LABS's investment exposure in the US will be extremely limited without a NASDAQ listing ...more

Comment